Works matching AU Bakris, George L.

Results: 316
    1
    2
    3

    Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.

    Published in:
    2019
    By:
    • Bakris, George L.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Nowack, Christina;
    • Kolkhof, Peter;
    • Ferreira, Anna C.;
    • Schloemer, Patrick;
    • Filippatos, Gerasimos;
    • Bakris, George L;
    • Anker, Stefan D;
    • Ruilope, Luis M;
    • Ferreira, Anna C;
    • on behalf of the FIDELIO-DKD study investigators;
    • FIDELIO-DKD study investigators
    Publication type:
    journal article
    4
    5
    6
    7

    A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease.

    Published in:
    Clinical Kidney Journal, 2023, v. 16, n. 2, p. 293, doi. 10.1093/ckj/sfac234
    By:
    • Agarwal, Rajiv;
    • Pitt, Bertram;
    • Palmer, Biff F;
    • Kovesdy, Csaba P;
    • Burgess, Ellen;
    • Filippatos, Gerasimos;
    • Małyszko, Jolanta;
    • Ruilope, Luis M;
    • Rossignol, Patrick;
    • Rossing, Peter;
    • Pecoits-Filho, Roberto;
    • Anker, Stefan D;
    • Joseph, Amer;
    • Lawatscheck, Robert;
    • Wilson, Daniel;
    • Gebel, Martin;
    • Bakris, George L
    Publication type:
    Article
    8
    9
    10
    11

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    12

    Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
    By:
    • Perakakis, Nikolaos;
    • Bornstein, Stefan R.;
    • Birkenfeld, Andreas L.;
    • Linkermann, Andreas;
    • Demir, Münevver;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Rossing, Peter;
    • Ruilope, Luis M.;
    • Kolkhof, Peter;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Bakris, George L.
    Publication type:
    Article
    13

    Back Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    14

    The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
    By:
    • Rossing, Peter;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Billings, Liana K.;
    • Green, Jennifer B.;
    • Koya, Daisuke;
    • Mosenzon, Ofri;
    • Pantalone, Kevin M.;
    • Ahlers, Christiane;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scalise, Andrea;
    • Bakris, George L.
    Publication type:
    Article
    15

    Cover Image.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    16

    Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
    By:
    • McGill, Janet B.;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Bakris, George L.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Birkenfeld, Andreas L.;
    • Caramori, Maria L.;
    • Brinker, Meike;
    • Joseph, Amer;
    • Lage, Andrea;
    • Lawatscheck, Robert;
    • Scott, Charlie;
    • Rossing, Peter
    Publication type:
    Article
    17
    18

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
    By:
    • Rossing, Peter;
    • Agarwal, Rajiv;
    • Anker, Stefan D.;
    • Filippatos, Gerasimos;
    • Pitt, Bertram;
    • Ruilope, Luis M.;
    • Fonseca, Vivian;
    • Umpierrez, Guillermo E.;
    • Caramori, Maria Luiza;
    • Joseph, Amer;
    • Lambelet, Marc;
    • Lawatscheck, Robert;
    • Bakris, George L.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.

    Published in:
    Blood Pressure, 2012, v. 21, n. 2, p. 82, doi. 10.3109/08037051.2011.598699
    By:
    • Kjeldsen, Sverre E.;
    • Jamerson, Kenneth A.;
    • Bakris, George L.;
    • Pitt, Bertram;
    • Dahlöf, Björn;
    • Velazquez, Eric J.;
    • Hua, Tsushung A.;
    • Kelly, Roxzana Y.;
    • Zappe, Dion;
    • Hester, Allen;
    • Tuomilehto, Jaakko;
    • Östergren, Jan;
    • Ibsen, Hans;
    • Weber, Michael
    Publication type:
    Article
    28

    Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH Study.

    Published in:
    Blood Pressure, 2008, v. 17, n. 1, p. 7, doi. 10.1080/08037050801972857
    By:
    • Kjeldsen, Sverre E.;
    • Jamerson, Kenneth A.;
    • Bakris, George L.;
    • Pitt, Bertram;
    • Dahlöf, Björn;
    • Velazquez, Eric J.;
    • Gupte, Jitendra;
    • Staikos, Linda;
    • Hua, Tsushung A.;
    • Shi, Victor;
    • Hester, Allen;
    • Tuomilehto, Jaakko;
    • Östergren, Jan;
    • Ibsen, Hans;
    • Weber, Michael;
    • for the Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH) Investigators
    Publication type:
    Article
    29

    Exceptional early blood pressure control rates: The ACCOMPLISH trial.

    Published in:
    Blood Pressure, 2007, v. 16, n. 2, p. 80, doi. 10.1080/08037050701395571
    By:
    • Jamerson, Kenneth;
    • Bakris, George L.;
    • Dahlöf, Björn;
    • Pitt, Bertram;
    • Velazquez, Eric;
    • Gupte, Jitendra;
    • Lefkowitz, Martin;
    • Hester, Allen;
    • Shi, Victor;
    • Kjeldsen, Sverre E.;
    • Cushman, William;
    • Papademetriou, Vasilios;
    • Weber, Michael
    Publication type:
    Article
    30
    31

    Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: A hypertensive population at high cardiovascular risk.

    Published in:
    Blood Pressure, 2007, v. 16, n. 1, p. 13, doi. 10.1080/08037050701217643
    By:
    • Weber, Michael A.;
    • Bakris, George L.;
    • Dahlöf, Björn;
    • Pitt, Bertram;
    • Velazquez, Eric;
    • Gupte, Jitendra;
    • Lefkowitz, Martin;
    • Hester, Allen;
    • Shi, Victor;
    • Weir, Matthew;
    • Kjeldsen, Sverre;
    • Massie, Barry;
    • Nesbitt, Shawna;
    • Ofili, Elizabeth;
    • Jamerson, Kenneth;
    • for the Accomplish Investigators
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.

    Published in:
    2015
    By:
    • Bakris, George L;
    • Agarwal, Rajiv;
    • Chan, Juliana C;
    • Cooper, Mark E;
    • Gansevoort, Ron T;
    • Haller, Hermann;
    • Remuzzi, Giuseppe;
    • Rossing, Peter;
    • Schmieder, Roland E;
    • Nowack, Christina;
    • Kolkhof, Peter;
    • Joseph, Amer;
    • Pieper, Alexander;
    • Kimmeskamp-Kirschbaum, Nina;
    • Ruilope, Luis M;
    • Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group
    Publication type:
    journal article
    38

    Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy.

    Published in:
    JAMA: Journal of the American Medical Association, 2015, v. 314, n. 9, p. 884, doi. 10.1001/jama.2015.10081
    By:
    • Bakris, George L.;
    • Agarwal, Rajiv;
    • Chan, Juliana C.;
    • Cooper, Mark E.;
    • Gansevoort, Ron T.;
    • Haller, Hermann;
    • Remuzzi, Giuseppe;
    • Rossing, Peter;
    • Schmieder, Roland E.;
    • Nowack, Christina;
    • Kolkhof, Peter;
    • Joseph, Amer;
    • Pieper, Alexander;
    • Kimmeskamp-Kirschbaum, Nina;
    • Ruilope, Luis M.
    Publication type:
    Article
    39
    40
    41
    42

    Effect of Aliskiren on Progression of Coronary Disease in Patients With Prehypertension.

    Published in:
    JAMA: Journal of the American Medical Association, 2013, v. 310, n. 11, p. 1135, doi. 10.1001/jama.2013.277169
    By:
    • Nicholls, Stephen J.;
    • Bakris, George L.;
    • Kastelein, John J. P.;
    • Menon, Venu;
    • Williams, Bryan;
    • Armbrecht, Juergen;
    • Brunel, Patrick;
    • Nicolaides, Maria;
    • Hsu, Amy;
    • Bo Hu;
    • Hui Fang;
    • Rishi Puri;
    • Kiyoko Uno;
    • Yu Kataoka;
    • Bash, Dianna;
    • Nissen, Steven E.
    Publication type:
    Article
    43
    44

    Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.

    Published in:
    2018
    By:
    • Chin, Melanie P.;
    • Bakris, George L.;
    • Block, Geoffrey A.;
    • Chertow, Glenn M.;
    • Goldsberry, Angie;
    • Inker, Lesley A.;
    • Heerspink, Hiddo J.L.;
    • O’Grady, Megan;
    • Pergola, Pablo E.;
    • Wanner, Christoph;
    • Warnock, David G.;
    • Meyer, Colin J.;
    • O'Grady, Megan
    Publication type:
    journal article
    45

    The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.

    Published in:
    2018
    By:
    • Jardine, Meg J.;
    • Mahaffey, Kenneth W.;
    • Neal, Bruce;
    • Agarwal, Rajiv;
    • Bakris, George L.;
    • Brenner, Barry M.;
    • Bull, Scott;
    • Cannon, Christopher P.;
    • Charytan, David M.;
    • de Zeeuw, Dick;
    • Edwards, Robert;
    • Greene, Tom;
    • Heerspink, Hiddo J.L.;
    • Levin, Adeera;
    • Pollock, Carol;
    • Wheeler, David C.;
    • Xie, John;
    • Zhang, Hong;
    • Zinman, Bernard;
    • Desai, Mehul
    Publication type:
    journal article
    46

    Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.

    Published in:
    2014
    By:
    • Ruilope, Luis M;
    • Agarwal, Rajiv;
    • Chan, Juliana C;
    • Cooper, Mark E;
    • Gansevoort, Ron T;
    • Haller, Hermann;
    • Remuzzi, Giuseppe;
    • Rossing, Peter;
    • Schmieder, Roland E;
    • Nowack, Christina;
    • Ferreira, Anna C;
    • Pieper, Alexander;
    • Kimmeskamp-Kirschbaum, Nina;
    • Bakris, George L
    Publication type:
    journal article
    47

    Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy.

    Published in:
    American Journal of Nephrology, 2015, v. 40, n. 6, p. 572, doi. 10.1159/000371497
    By:
    • Ruilope, Luis M.;
    • Agarwal, Rajiv;
    • Chan, Juliana C.;
    • Cooper, Mark E.;
    • Gansevoort, Ron T.;
    • Haller, Hermann;
    • Remuzzi, Giuseppe;
    • Rossing, Peter;
    • Schmieder, Roland E.;
    • Nowack, Christina;
    • Ferreira, Anna C.;
    • Pieper, Alexander;
    • Kimmeskamp-Kirschbaum, Nina;
    • Bakris, George L.
    Publication type:
    Article
    48
    49
    50